The Hypoglycemic Effect of Oat Oligopeptides in Diabetic Rats

Xin-ran LIU,Si-qi LIU,Chao HOU,Lan WU,Rui-xue MAO,Hui-juan MA,Yong LI,Jun-bo WANG
DOI: https://doi.org/10.3969/j.issn.1006-9577.2018.04.011
2018-01-01
Abstract:[Objective] To study the hypoglycemic effects of oat oligopeptides in high-calorie diet and streptozotocin induced diabetic rats.[Method] Type 2 diabetes Sprague Dawley rats model were induced by high-calorie diet for 45 days combined with two times intraperitoneal injection of 30 mg/kg streptozotocin with a 6-day interval between the two injections.Rats with type 2 diabetes were randomly divided into seven groups including three oat oligopeptides groups (0.50,1.00,2.00g/kg · BW),diabetic model group,metformin control group,whey protein control group and normal control group.The fasting glucose,the area under the curve of blood glucose and blood lipid (serum total cholesterol,triglyceride,high density lipoprotein cholesterol and low density lipoprotein cholesterol) were measured after 15 weeks-intervention.[Result] Oat oligopeptides could decrease the fasting blood glucose level and improve the glucose tolerance in diabetic rats (P <0.05),and the optimal dose was 2.00g/kg · BW.[Conclusion] Long-term oat oligopeptides intervention has a hypoglycemic effect by reducing the fasting glucose level and the area under the curve of blood glucose.
What problem does this paper attempt to address?